Skip to main content
The Globe and Mail
Support Quality Journalism
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); }
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 191.64
Day High 193.38
Open:193.01
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan plc, formerly known as Actavis plc, is headquartered in Dublin, Ireland.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

The global immunosuppressant drugs market is projected to register growth at a CAGR of 4.17% during the projected period, 2019-2028
- PR Newswire - PRF - Tue Jun 2, 12:00PM CDT
PR Newswire - PRF - CMTX
Tue Jun 2, 12:00PM CDT
, /PRNewswire/ --The global immunosuppressant drugs market is projected to register growth at a CAGR of 4.17% during the projected period, 2019-2028. The growing incidences of autoimmune disorders, the growing pharmaceutical industry, and the increase in organ transplantation, are the major factors fueling the market growth.Read the full report: Organ transplantation has been on the rise across the globe.This is because of the prevalence of genetic conditions like cystic fibrosis, heart defect, and polycystic kidney disease.Infections like hepatitis, damage to organs due to chronic conditions like diabetes, physical injuries, are other factors that are responsible for an organ transplant.Immunosuppressive drugs come into the scene post organ transplantation, while combatting the hyper-immune response of the patient's immune system.Thus, the growing demand for organ transplantation procedures is estimated to have a major impact on the growth of the market. Though immunosuppressive drugs have improved the outcome of organ transplantation, the side effects of such drugs can be serious, and this is one of the major factors hindering the market growth.The global immunosuppressant drugs market is geographically analyzed through the regions of , , , and the rest of the world.The region garnered the largest market share, while the region is slated to record the highest growth rate by the end of the forecast period.The government funding, prevailing auto-immune diseases, and increasing demands for organ transplantation, contribute to the market prospects of .The competitive environment of the market is evaluated to be stiff, given the workings of the pharmaceutical business. Some of the leading companies in the market are Allergan Plc (Acquired By AbbVie Inc), Bristol-Myers Squibb Company, Cipla Ltd, AbbVie Inc, Astellas Pharma Inc, etc.• Explore key findings of the overall market• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions• Market Segmentation cater to a thorough assessment of key segments with their market estimations• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share• Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments1. ABBVIE INC2. ALLERGAN PLC (ACQUIRED BY ABVIE INC)3. ASTELLAS PHARMA INC4. -MYERS SQUIBB COMPANY5. CIPLA LTD6. DR. REDDY'S LABORATORIES LTD7. F HOFFMANN-LA ROCHE AG8. GLAXOSMITHKLINE PLC9. INTAS PHARMACEUTICALS LTD (ACCORD HEALTHCARE LTD)10. JANSSEN PHARMACEUTICALS NV (JHONSON & JHONSON)11. MYLAN NV12. NOVARTIS INTERNATIONAL AG (SANDOZ)13. PFIZER INC14. SANOFI SA15. VELOXIS PHARMACEUTICALSRead the full report: About ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: US: (339)-368-6001 Intl: +1 339-368-6001
Hyaluronic Acid Based Dermal Fillers Market - Growth, Trends, and Forecast (2020 - 2025)
- PR Newswire - PRF - Tue Jun 2, 7:40AM CDT
PR Newswire - PRF - CMTX
Tue Jun 2, 7:40AM CDT
, /PRNewswire/ --
GLOBAL MEDICAL AESTHETICS MARKET FORECAST 2019-2028
- PR Newswire - PRF - Tue Jun 2, 7:10AM CDT
PR Newswire - PRF - CMTX
Tue Jun 2, 7:10AM CDT
, /PRNewswire/ --
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 181.21 +6.52% increase
on 04/09/20
Period Open:181.08
Price movement based on the high, low and last over the given period.
196.45 -1.75% decrease
on 05/06/20
+11.94 (+6.59%) increase
since 04/08/20
3-Month 158.67 +21.65% increase
on 03/18/20
Period Open:197.05
Price movement based on the high, low and last over the given period.
202.21 -4.55% decrease
on 02/12/20
-4.03 (-2.05%) decrease
since 02/07/20
52-Week 114.27 +68.92% increase
on 06/17/19
Period Open:140.05
Price movement based on the high, low and last over the given period.
202.21 -4.55% decrease
on 02/12/20
+52.97 (+37.82%) increase
since 05/08/19

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2020.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies